Additive effects of cepharanthin in CDDP/hyperthermia combination therapy against transplantable human esophageal cancer in nude mice
- PMID: 8005810
- DOI: 10.1016/0360-3016(94)90449-9
Additive effects of cepharanthin in CDDP/hyperthermia combination therapy against transplantable human esophageal cancer in nude mice
Abstract
Purpose: Additive effects of cepharanthin in CDDP/hyperthermia combination therapy were evaluated.
Methods and materials: Nude mice bearing a transplantable human esophageal cancer (ES0-2), classified histologically as a moderately differentiated squamous cell carcinoma, were treated with cepharanthin (20 mg/kg IP) in addition to cis-diamminedichloroplatinum(II) (CDDP; 4 mg/kg IP) and/or hyperthermia at 42 degrees C for 30 min, to determine the additive effects of cepharanthin. Furthermore, effects of cepharanthin on intratumoral concentration of CDDP were evaluated.
Results: Cepharanthin itself did not have an anti-tumor effect. This agent did not enhance the anti-tumor effect of CDDP alone, but enhanced the anti-tumor effects of both 42 degrees C hyperthermia alone, and combination therapy with CDDP and 42 degrees C hyperthermia. The concentration of CDDP in the tumors treated by 42 degrees C hyperthermia was slightly higher than in nonheated tumors. Cepharanthin did not affect the intratumoral concentration of CDDP, irrespective of whether hyperthermia was applied.
Conclusion: Cepharanthin enhanced the effect of CDDP/hyperthermia combination therapy through thermoenhancing effect.
Similar articles
-
Effects of pre-heating on cis-diamminedichloroplatinum(II)-hyperthermia-induced tumour growth depression of transplantable human oesophageal cancer to nude mice.Int J Hyperthermia. 1993 Sep-Oct;9(5):699-708. doi: 10.3109/02656739309032057. Int J Hyperthermia. 1993. PMID: 8245581
-
Hyperthermic enhancement of cis-diamminedichloroplatinum (II)-induced DNA damage in human esophageal cancer transplantable to nude mice.Anticancer Res. 1993 Nov-Dec;13(6A):1989-97. Anticancer Res. 1993. PMID: 8297105
-
Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells.Int J Oncol. 2007 Oct;31(4):761-8. Int J Oncol. 2007. PMID: 17786306
-
Positive interactions between human interferon and cepharanthin against human cancer cells in vitro and in vivo.Cancer Chemother Pharmacol. 1994;35(1):10-6. doi: 10.1007/BF00686278. Cancer Chemother Pharmacol. 1994. PMID: 7527303
-
Reduction of cellular cisplatin resistance by hyperthermia--a review.Int J Hyperthermia. 1997 Sep-Oct;13(5):439-57. doi: 10.3109/02656739709023545. Int J Hyperthermia. 1997. PMID: 9354931 Review.
Cited by
-
Pharmacological Activity of Cepharanthine.Molecules. 2023 Jun 27;28(13):5019. doi: 10.3390/molecules28135019. Molecules. 2023. PMID: 37446681 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical